The metabolism of tazobactam/piperacillin (TAZ/PIPC) in some animals was studied using in vitro and in vitro examinations. The following results were obtained. 1. After intravenous administration of 14C-TAZ/PIPC or TAZ/14C-PIPC to rats, metabolites were investigated in plasma, urine and bile. M-1 was identified as a metabolite of TAZ having a structure of the β-lactam ring-opening product. In the urine, about 70% of unchanged TAZ, about 17% of M-1, and about 25% of unchanged PIPC were excreted for 24h, and in the bile about 60% of unchanged PIPC was excreted for 24h. 2. Plasma and urinary bioactive metabolites in rats, dogs and monkeys were examined by TLC-bioautography. No bioactive metabolites were detected in any specimens. 3. In vitro, stability of TAZ in mice plasma and tissue homogenate was examined. The metabolite M-1 was produced in plasma, kidney and small intestine homogenates. © 1994, Japanese Society of Chemotherapy. All rights reserved.
CITATION STYLE
Matsushita, H., Komuro, M., Maeda, T., Minami, Y., & Sakawa, K. (1994). Studies on metabolism of tazobactam/piperacillin in some animals. CHEMOTHERAPY, 42, 198–205. https://doi.org/10.11250/chemotherapy1953.42.Supplement2_198
Mendeley helps you to discover research relevant for your work.